(Q38340062)

2 September 2017

title

Glycated albumin activates PAI-1 transcription through Smad DNA binding sites in mesangial cells (English)

1 reference

2 September 2017

1 reference

Hyun Soon Lee

1

1 reference

2 September 2017

Kyung Chul Moon

2

1 reference

2 September 2017

Chi Young Song

3

1 reference

2 September 2017

Bong Cho Kim

4

1 reference

2 September 2017

Suxia Wang

5

1 reference

2 September 2017

Hye Kyoung Hong

6

1 reference

2 September 2017

publication date

15 June 2004

1 reference

American Journal of Physiology - Renal Physiology

2 September 2017

published in

1 reference

2 September 2017

volume

287

1 reference

2 September 2017

issue

4

1 reference

2 September 2017

page(s)

F665-72

1 reference

Intervention strategies to prevent pathogenetic effects of glycated albumin

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Albumin modified by Amadori glucose adducts activates mesangial cell type IV collagen gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Amadori glucose adducts modulate mesangial cell growth and collagen gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

A novel method for generating region-specific monoclonal antibodies to modified proteins. Application to the identification of human glucosylated low density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Regulation of plasminogen activator inhibitor-1 expression by transforming growth factor-beta -induced physical and functional interactions between smads and Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Specificity in transforming growth factor beta-induced transcription of the plasminogen activator inhibitor-1 gene: interactions of promoter DNA, transcription factor muE3, and Smad proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

mRNA expression of urokinase and plasminogen activator inhibitor-1 in human crescentic glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Role of TGF-beta signaling in extracellular matrix production under high glucose conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Techniques for using antisense oligodeoxyribonucleotides to study gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Transcriptional control by the TGF-beta/Smad signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

TGF-beta signaling by Smad proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Extracellular signal-regulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor-beta1 on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Biphasic regulation of plasminogen activator/inhibitor by LDL in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Smad4/DPC4 and Smad3 mediate transforming growth factor-beta (TGF-beta) signaling through direct binding to a novel TGF-beta-responsive element in the human plasminogen activator inhibitor-1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor beta-induced smad-dependent transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Role of Smad4 on TGF-beta-induced extracellular matrix stimulation in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

An absolute method for protein determination based on difference in absorbance at 235 and 280 nm

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Mechanism of activation of the TGF-beta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Human Smad3 and Smad4 are sequence-specific transcription activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Receptor-associated Mad homologues synergize as effectors of the TGF-beta response

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00034.2004

10.1152/AJPRENAL.00034.2004

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference